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Abstract
Objective: Determine whether testicular sperm extractions and pregnancy outcomes are influenced by male and female
infertility diagnoses, location of surgical center and time to cryopreservation.
Patients: One hundred and thirty men undergoing testicular sperm extraction and 76 couples undergoing 123 in vitro
fertilization cycles with testicular sperm.
Outcome Measures: Successful sperm recovery defined as 1–2 sperm/0.5 mL by diagnosis including obstructive
azoospermia (n = 60), non-obstructive azoospermia (n = 39), cancer (n = 14), paralysis (n = 7) and other (n = 10). Obstructive
azoospermia was analyzed as congenital absence of the vas deferens (n = 22), vasectomy or failed vasectomy reversal
(n = 37) and ‘‘other’’(n = 1). Sperm recovery was also evaluated by surgical site including infertility clinic (n = 54), hospital
operating room (n = 67) and physician’s office (n = 11). Treatment cycles were evaluated for number of oocytes, fertilization,
embryo quality, implantation rate and clinical/ongoing pregnancies as related to male diagnosis, female diagnosis, and use
of fresh or cryopreserved testicular sperm.
Results: Testicular sperm recovery from azoospermic males with all diagnoses was high (70 to 100%) except nonobstructive azoospermia (31%) and was not influenced by distance from surgical center to laboratory. Following in vitro
fertilization, rate of fertilization was significantly lower with non-obstructive azoospermia (43%, p = ,0.0001) compared to
other male diagnoses (66%, p = ,0.0001, 59% p = 0.015). No differences were noted in clinical pregnancy rate by male
diagnosis; however, the delivery rate per cycle was significantly higher with obstructive azoospermia (38% p = 0.0371)
compared to diagnoses of cancer, paralysis or other (16.7%). Women diagnosed with diminished ovarian reserve had a
reduced clinical pregnancy rate (7.4% p = 0.007) compared to those with other diagnoses (44%).
Conclusion: Testicular sperm extraction is a safe and effective option regardless of the etiology of the azoospermia. The
type of surgical center and/or its distance from the laboratory was not related to success. Men with non-obstructive
azoospermia have a lower chance of successful sperm retrieval and fertilization.
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epididymal or vasal sperm. Ultimately, the location and method of
sperm extraction does not affect pregnancy rate. [3–6].
Obstructive azoospermia accounts for 40% of men who present
to infertility practices with azoospermia and is often successfully
treated with ICSI using surgically collected sperm. [7] Men with
non-obstructive azoospermia (NOA) may have severely deficient
spermatogenesis and inadequate sperm production. [8] Nonobstructive azoospermia is most frequently characterized by an
elevated FSH and small volume testes, and treatment historically
involved donor inseminations or adoption. Sperm production is

Introduction
Since its introduction in 1992, in vitro fertilization (IVF) with
intracytoplasmic sperm injection (ICSI) has proved to be the only
viable option for patients with azoospermia desiring their own
genetic offspring. [1,2] Sperm can be obtained directly via the
epididymis, either percutaneously (PESA) or microsurgically
(MESA), or by direct sampling of the testis either via needle
aspiration (TESA) or direct biopsy (TESE). When extracted from
the testes, sperm have not undergone full maturation compared to
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vicinity of the IVF laboratory, thus requiring transportation of the
fresh specimen to the laboratory for ICSI or cryopreservation.
Over a 15 year period, our TESE’s were performed at three
different locations at varying distances from the IVF laboratory.
Additionally, we have had two urologists performing the
procedures over that time period.
We present our institutional experience over the last fifteen
years as it relates to IVF-ICSI using TESE sperm. We examined
our sperm recovery rate based on male factor infertility diagnosis
and IVF-ICSI outcomes comparing fresh and frozen TESE sperm.
Cycle outcomes (i.e pregnancy rate and live birth rate) were
correlated with male factor diagnosis, as well as co-existing female
factor infertility. In addition, we present data on outcomes as they
relate to the location and surgical provider.

not uniform throughout the testes in men with NOA which leads
to difficulty in surgically isolating sperm. However, if sperm are
recovered, subsequent IVF-ICSI treatment can produce viable
offspring for these patients. [8].
Testicular sperm extraction may also be indicated in patients
recently diagnosed with cancer due to deficient sperm in the
ejaculate or an inability to collect. Alkylating agents are the most
toxic to Leydig and Sertoli cells leading to decreased testicular
volume and increased FSH. [9] In addition, accidents and critical
illnesses, along with requests for posthumous reproduction are
increasing the need for TESE procedures. [10,11]The ability to
cryopreserve sperm after testicular extraction allows better
coordination with oocyte retrieval.While cryopreservation of
testicular sperm is equal to fresh, even among some cohorts of
men with NOA [12–16], concern regarding limited sperm viability
during the freeze-thaw in men with NOA [8] remain prompting
some to perform TESE on the day of egg retrieval to avoid sperm
loss from the freeze-thaw [17].
While the diagnosis itself has remained stable, male factor
infertility remains the most frequent diagnosis among IVF cycles
performed by Society of Assisted Reproductive Technologies
(SART) Member Clinics and overall IVF utilization continues to
rise. [18] In an effort to optimize patient scheduling, it is not
uncommon for surgeons to perform TESE procedures outside the

Materials and Methods
Patient Selection
This study was approved by the Human Studies Committee of
Washington University School of Medicine and included all TESE
procedures and subsequent IVF-ICSI cycles performed in our
Division from January 1995 through December 2009 (Table 1).
The Human Studies Committee agreed that it was a record review

Table 1. Diagnosis, age and cryopreservation results for patients undergoing testicular sperm extraction.

Diagnosis

n

Mean age ±SD

Obstructive Azoospermia

60

39.868.2

60 (100)

Congenital Absence of Vas Deferens

22

33.467.8a

22 (100)

Vasectomy/Failed Vasectomy Repair

37

43.466.0a

37 (100)

Other

1

46

1 (100)

No. with samples cryopreserved (%)

Non-Obstructive Azoospermia

39

36.066.8

12 (31)

High FSH

4

34.568.3

2 (50)

Sertoli Cell Only

6

35.063.2

2 (33)

Maturation Arrest

8

35.667.0

2 (25)

Spermatogenic hypoplasia

1

31.0

0

Unknown

20

36.967.8

6 (30)

Cancer

14

36.6611.5

10 (71)

Testicular

6

30.0+3.6b

3 (50)

Prostate

2

53.5+3.5b

2 (100)

ALL

1

31

1(100)

Bladder

1

63

1 (100)

Hodgkin’s

1

35

1 (100)

Type not known

3

31.7+2.5b

2 (67)

Paralysis

7

35.0+7.0

7 (100)

Other

10

34.4+3.7

10 (100)

Kidney transplant

1

27.0

1 (100)

Autoimmune disease

1

38.0

1 (100)

Stroke

1

39

1 (100)

Testicular torsion

2

32.5+2.1

2 (100)

Varicocoele/varicocoele repair

3

34.0+1.0

3 (100)

Anejaculation

1

34

1 (100)

Electrocution

1

39

1 (100)

a

p = 0.0001;
= 0.0001.
doi:10.1371/journal.pone.0069838.t001

b
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Table 2. Effect of distance of surgical suite from laboratory and surgeon on sperm recovery and cryopreservation of TESE samples.
Sitea/MD

n

Mean age±SD

No. of cases with NOA (%)

No. samples cryopreserved (%)

Site 1 (0 miles)

54

36.768.4

30 (55)

40 (74)

Site 2 (0.74 miles)

67

38.667.5

39 (58)

49 (73)

Site 3 (15 miles)

11

35.569.0

3 (27)

10 (91)

Urologist 1

86

37.967.9

42 (49)

64 (74)

Urologist 2

46

37.168.3

30 (65)

35 (76)

a
(distance from surgical suite from IVF laboratory).
Note: NOA = non-obstructive azoospermia.
doi:10.1371/journal.pone.0069838.t002

and did not pose a risk to the participants since all data was deidentified.
TESE surgical procedures were performed by two urologists at
three different locations: 1) operating room (OR) adjacent to
laboratory, 2) OR in another building approximately 0.74 miles
from laboratory, and 3) Ambulatory surgical center (ASC)
approximately 15 miles from the laboratory. At the second site,
an embryologist was present during the surgery to make an initial
examination of the tissue for the presence of spermatozoa and
transport the specimen to the laboratory for final processing.
There was no embryologist at the third location, and patients were
responsible for prompt transportation of the specimen, either with
a family member or a courier, to the laboratory where the
embryologist would review the sample. Couriers were instructed to
keep the specimen at body temperature during transport. The
time to transport from the third site was less than 30 minutes.

opened, and an ophthalmic clamp placed as a wound retractor.
With the testicle exposed, a 6.0 prolene suture was placed through
the tunica albuginea at the upper pole, anterior aspect of the
testicle as a stay suture. Microscissors or a #15 blade scalpel was
used to make a 2 mm incision and testicular tissue was expressed
by manipulating (squeezing) the gland. A small amount of tissue
was excised. This tissue was immediately placed in culture
medium, minced with sterile scissors, dispersed between two glass
slides, and studied under the microscope by an embryologist.
While the sample from the first site was being studied, one to two
other sites would be similarly biopsied. When a biopsy site yielding
spermatozoa was identified, additional tissue (10–15 mg) was
harvested. The biopsy sites were closed with 6.0 prolene and the
wound irrigated with saline prior to approximation of the fascia
with 3.0 chromic. The skin was closed with 4.0 chromic using a
simple, running stitch. A gauze dressing was applied and the
patient awakened.

TESE Surgery
Preparation and Cryopreservation of TESE Samples

Prior to presenting for a TESE, the men were required to have a
negative screen for HIV, hepatitis B and C and syphilis (RPR).
Following IV sedation, a small area of the scrotum is shaved,
prepped and outlined in a sterile field. A testicle was held by the
surgical assistant under the median raphe, and 1% lidocaine was
injected as a local anesthetic. A small (5 mm) incision was made
longitudinally, and the incision carried down through the fascia
with a bovie cautery. The tunical vaginalis was exposed and

Upon arrival to the laboratory, tissue was cut into 1 mm2 blocks
in HEPES-HTF (Irvine Scientific, Santa Ana, CA)+5% Human
Serum Albumin Solution (HSA; Irvine Scientific) followed by
mincing with scissors or the bottom of a sterile 5 ml tube (Falcon
2058, Beckton Dickenson, Franklin Lakes, NJ). Periodically, a
small portion of the minced fluid was examined under the inverted
microscope (Olympus Inc., Center Valley, PA 18034) for the

Table 3. Effect of Male Diagnosis on TESE/IVF Outcome.

Obstructive

Non-Obstructive

Othera

Total

No. Retrievals

72

19

32

123

No. Patients

42

15

19

76

Mean No. 2PN

6.260.50b

4.160.95b

4.660.57

5.560.37

Fertilization Rate

439/670 (66%)c,d

77/179 (43%)c,e

142/257 (55%)d,e

658/1106 (59%)

Implantation Rate

48/167 (29%)

7/27 (26%)

13/65 (20%)

68/259 (26%)

Delivery Rate per ET (all patients)

26/68 (38%)f

3/14 (21%)

5/30 (16.7%)f

34 (30.4%)

g,h

Delivery Rate per Patient

26/42 (62%)

Mean age of Female partner (range)

33.360.60 (24–43)

3/15 (20%)

g

33.860.93 (26–40)

5/19 (26.3%)h

34/76 (44.7%)

31.660.84 (23–43)

33.160.44 (23–43)

a

includes all male diagnoses except obstructive and non-obstructive azoospermia.
p = 0.044;
c
p,0.0001;
d
p = 0.049;
e
p = 0.015;
f
p = 0.0371;
g
p = 0.0070;
h
p = 0.0134.
doi:10.1371/journal.pone.0069838.t003
b
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presence of spermatozoa. Approximately 0.5 ml aliquots of fluid
and minced tissue found to contain spermatozoa (motile and/or
non-motile) were transferred to cryovials (Nalge Nunc Intl.,
Rochester, NY) for subsequent cryostorage. All processing was
performed in a sterile hood at room temperature and processing
results were reported as the number of motile and/or nonmotile
spermatozoa seen per 20X microscopic field. Processed samples
containing no spermatozoa were not cryopreserved. If the sample
or a portion of the sample was to be used fresh for ICSI, it was
processed as described below and stored at 37uC, 5% CO2 until
the time of the procedure.
Cryopreservation of TESE samples was performed by adding
an equal volume of Test yolk buffer (TYB) with 12% glycerol
(Irvine Scientific) drop wise at a rate of 1/4th the original sample
volume every 5 minutes. After insuring sufficient mixing of TYB
and sample, cryovials were incubated at 2.0uC for 60 minutes,
followed by slow cooling in liquid nitrogen vapors using a TaylorWarton Freezing rack (Praxair Dist. Inc., St Louis, MO).
Following freezing, cryovials were stored in liquid nitrogen until
time of thaw.

Table 4. Comparison of IVF Outcome between TESE for
Congenital Absence of Vas and Vasectomized/Failed
Vasectomy Reversals.

CAV

Vasectomy

No. Retrievals

29

42

No. Patients

18

23

Mean No. Mature Oocytes

11.861.2a

8.360.60a

Mean No. 2PN

8.0+0.91b

5.1+0.49b

Fertilization Rate

230/341 (67%)

215/349 (62%)

Mean No. Embryos Transferred

2.260.18

2.560.18

No. Cycles with ET

28

40

Implantation Rate

26/64 (41%)e

22/103 (21%)e

Clinical Pregnancies per ET

14/28 (50%)

14/40 (35%)

Delivery Rate per ET

12/28 (43%)

14/40 (35%)

Delivery Rate per Patient

12/18 (67%)

14/23 (61%)

Mean age of Female partner
(range)

30.560.77c (24–38) 35.560.72c (26–43)

Mean age of Male partner (range)

34.761.5d (25–54)

Ovarian Stimulation and Oocyte Retrieval Procedures

44.960.85d (33–55)

Ovarian stimulation was performed using gonadotropins in
combination with a GnRH antagonist or GnRH agonist following
established protocols. Serum estradiol was measured at baseline
and serially after gonadotropin administration,depending on the
stimulation protocol and then as needed until retrieval. Vaginal
ultrasounds were performed concomitantly with estradiol levels.

a

p = 0.0055;
b
p = 0.0047;
c,d
p = 0.0001;
e
p = 0.0088.
doi:10.1371/journal.pone.0069838.t004

Table 5. Effect of Female Infertility on IVF/TESE Cycles.

No Known Contributing Female
Infertility

Plus Female Infertilitya
b

DOR
31

No. Retrievals

72

19

No. Patients

50

12

Mean No. Mature Oocytes

11.060.56c

9.461.1d

Mean No. 2PN

6.860.50e

4.760.76f

2.960.44e,f

Fertilization Rate

480/792 (60.6%)g

90/178 (50.6%)g

86/149 (57.7%)

15
4.860.61c,d

Mean No. Embryos Transferred

2.460.13

2.160.23

2.060.17

No. Cycles with Embryo Transfer

68

16

27

Implantation Rate

55/163 (33.7%)k

9/36 (25%)l

l

n

3/57 (5.3%)
2/27 (7.4%)

k,l
l,n

Clinical Pregnancies per Embryo Transfer

33/68 (48.5%)

7/16 (44%)

SABs per ET

6/68 (8.8%)

2/16 (12.5%)

1/27 (3.7%)

Multiple Rate per clinical Pregnancy

19/33 (57.5%)

2/7 (28.6%)

1/2 (50%)

Delivery Rate per ET

27/68 (39.7%)o

5/16 (31.3%)p

1/27 (3.7%)o,p

Delivery Rate per Patient

27/50 (54%)q

5/12 (41.7%)

1/15 (6.7%)q

Mean age of female partner (range)

31.860.55h (23–43)

33.561.3 (27–43)

36.060.59 h (29–42)

Mean age of male partner (range)

i

j

37.160.85 (25–63)

38.661.7 (27–48)

45.161.4

i,j

(33–56)

a

excludes Diminished Ovarian Reserve (DOR) patients.
female diagnoses included endometriosis (1 retrieval), tubal (7), adhesions (2), PCO (2), and ovulation disorder (7).
p,0.0001;
d
p,0.0003;
f
p,0.0002,
e
p = 0.0147;
j
p = 0.0048;
l
p = 0.0094;
n
p = 0.0078;
o
p = 0.0003;
p
p = 0.0207;
q
p = 0.001.
doi:10.1371/journal.pone.0069838.t005
b

c,e,h,i,k,m
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Table 6. Comparison of IVF Cycles using either Frozen or Fresh TESE Samples.

Frozen TESE Sample

Fresh TESE Sample

No. Retrievals

114

21

No. Retrievals with Obstructive Azoospermia

70 (61.4%)

2 (9.5%)

Mean No. Mature Oocytes

9.060.50

10.461.1

Mean No. 2PN

5.660.40

4.960.88

Fertilization Rate

585/945 (61.9%)a

78/167 (46.7%)a

Mean No. Embryos Transferred

2.360.10

2.560.24

No. Cycles with Embryo Transfer

98 (86%)

13 (62%)

Implantation Rate

58/225 (25.8%)

8/33 (24.2%)

Clinical Pregnancies per Embryo Transfer

38/98 (38.8%)

5/13 (38.5%)

Delivery Rate per ET

30/98 (30.6%)

4/13 (30.8%)

Mean age of Female partner

33.360.49

32.060.90

Mean age of Male partner

39.960.84

36.661.2

a
p = 0.0003.
doi:10.1371/journal.pone.0069838.t006

Human chorionic gonadotropin (hCG)was administered when two
or more follicles were at least 17–18 mm in largest mean diameter.
Transvaginal follicular aspiration was performed approximately
36 hours later (day 0).

Embryo Transfer
Embryo transfers were performed on the morning of day 3 or
day 5 depending on the number of good quality embryos. When
multiple embryos were available, the Veeck criteria were used to
select the highest grade embryos for transfer. [19] All efforts were
made to follow American Society of Reproductive Medicine
(ASRM) embryo transfer guidelines. [20].
All transfers, regardless of day, were performed using a Wallace
catheter (Irvine Scientific) with the patient in the dorso-lithotomy
position with a full bladder. Patients were instructed to remain
resting on their backs for at least 30 minutes following the embryo
transfer. Progesterone in oil was administered on the day of
retrieval and then daily for 8 weeks unless a negative beta-hCG
was obtained.
All patients underwent an initial serum test for beta-hCG 12 to
14 days after embryo transfer. A clinical pregnancy was defined as
the presence of a gestational sac on ultrasound.

Preparation of TESE Samples for Intracytoplasmic Sperm
Injection (ICSI)
Preparation of cryopreserved TESE samples for ICSI was
performed the day of the oocyte retrieval. One or more cryovials
were removed from liquid nitrogen and thawed in a 31uC water
bath. The sample was then washed twice by centrifugation in
approximately 3 to 5 ml of IVC-TWO (In Vitro Care Inc.,
Frederick, MD) supplemented with 5% HSA. The final pellet was
resuspended in 0.1 to 0.2 ml of IVC-TWO+5% HSA and
incubated under oil at 37uC, 5% CO2. If at the time of ICSI,
no or few motile sperm were present in the sample, an equal
amount of 2 mM pentoxifylline (Sigma Chemical Co., St. Louis,
MO) in HEPES-HTF supplemented with 10% Synthetic Serum
Substitute (SSS, Irvine Scientific) was added to promote motility.
Fresh TESE samples were washed as described above and were
sometimes collected the day prior to oocyte retrieval and
incubated overnight for increased sperm motility. When necessary,
pentoxifylline was also used with the fresh TESE samples if no or
poor motility was found at the time of ICSI.

Statistical Analysis
Cycle demographics and treatment cycle variables were
compared using either a Kruskal-Wallis test or a one-way analysis
of variance. Proportions were analyzed with a chi-squared or
Fisher’s exact test. P-values ,0.05 were considered statistically
significant (GraphPad InStat version 5.1, GraphPad Software, San
Diego CA).

Intracytoplasmic Sperm Injection (ICSI) and Embryo
Culture

Results

Oocyte identification and oocyte and embryo culture were
performed using established protocols for in vitro fertilization and
intracytoplasmic sperm injection. Single oocytes, cultured in
0.1 mL droplets of IVC-TWO+5% SSS were injected with a
single sperm. Whenever possible, motile or twitching sperm with a
normal morphology were utilized. Injected oocytes were evaluated
approximately 18 hours later for pronuclear formation, and the
resulting embryos placed in 0.05- mL droplets of IVC-ONE
growth medium (In Vitro Care Inc.) supplemented with 10% SSS.
Embryo cleavage and morphology was evaluated again on the
morning of day 3. Embryos remaining in culture for a day 5
transfer or for possible cryopreservation at the blastocyst stage
were transferred to 0.05–mL droplets of IVC-THREE growth
medium (In Vitro Care Inc.) supplemented with 10% SSS.

One-hundred and thirty testicular sperm extraction (TESE)
procedures were performed at our center from January 1995
through December 2009. The most common diagnosis for TESE
among men at our center was obstructive azoospermia (46%).
Non-obstructive azoospermia (24%) and cancer (11%) followed in
frequency.
The average age of these men was thirty-six. Statistically
significant differences in age, however, were reached between men
with congenital bilateral absence of the vas deferens (CBAVD) and
men with a history of vasectomy (p = 0.0001). Additionally, men
diagnosed with testicular cancer were younger than men with
prostate cancer (p = 0.0001).
Recovery of sperm via TESE was 70% in cancer patients and
100% in men diagnosed with obstructive azoospermia, paralysis
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and other. Thirty-one percent of men diagnosed with NOA had
sperm available after TESE. (Table 1).
In evaluating the effect of surgeon and surgery site on successful
recovery and cryopreservation of sperm, there was no statistically
significant difference between the locations as far as a) patient age,
b) number of patients with non-obstructive azoospermia, and c)
number of samples cryopreserved. Additionally, when comparing
the two different surgeons at our facility, no statistically significant
differences in these three categories were found (Table 2).
Of the men who had TESE performed, 58% (76/130) went on
to use the sample in an in-vitro fertilization cycle. Of these 76 men,
those diagnosed with obstructive azoospermia (55%) comprised
the majority while 25% of those with other diagnoses (i.e cancer,
paralysis, testicular torsion, varicocele, etc) and 20% of men with
non-obstructive azoospermia were involved in an IVF cycle. The
mean age of the female partner was thirty three. The fertilization
rate was greater in the obstructive azoospermia group compared
with the non-obstructive azoospermia group (66% vs 43%,
p = ,0.0001). Additionally, the delivery rate in men undergoing
IVF with obstructive azoospermia was higher than men with nonobstructive azoospermia (62% vs. 20%; p = 0.007)(Table 3).
Men who had CBAVD had significantly younger female
partners (mean age 30.5, p = 0.0001) than men who had a prior
vasectomy (mean age 35.5, p = 0.0001). The associated embryo
implantation rate was higher in this group of men (41%, p = 0.009)
compared to that associated with men who had a prior vasectomy
(21%, p = 0.009). The delivery rate per patient differed (67% vs
61%) in men with CBAVD and prior vasectomy respectively, but
did not reach statistical significance (Table 4).
We also examined the effect of female infertility on TESE/ICSI
cycles at our center. Seventy-seven women underwent 122
retrievals involving a TESE/ICSI cycle. Of these women, 65%
(50/77) had no contributing female infertility factor, 19% (15/77)
had diminished ovarian reserve and 17% (12) had other
contributing female infertility factors (i.e endometriosis, tubal
factor, PCOS, ovulatory dysfunction). The implantation rate was
33.7%, 5.3%, and 25% in the three groups, respectively. The
delivery rate per patient was 54%, 6.7% and 41.7%, respectively.
These differences were all statistically significant (p,0.05)
(Table 5).
The number of in-vitro fertilization initiated retrievals that
utilized either fresh or frozen TESE spermatozoa was one hundred
and thirty-six. Of these retrievals, 84% (114/136) involved frozen
TESE sperm and the remaining 16% used fresh sperm. A
statistically significant difference in fertilization rate was noted
between frozen (62%) and fresh (47%) sperm, respectively
(p = 0.0003) There was no difference between the delivery rate.
(Table 6).

States up from 2,462 in 1997. [34] One unique aspect of our study
was the incorporation of location and surgeon information into the
outcomes data as it related to cryopreservation. This has not been
previously reported, and it is of interest as many IVF practitioners
utilize an offsite urologist for the TESE. We did not find that the
location of the TESE procedure or the urologist performing the
procedure contributed to any difference in the ability to
cryopreserve sperm for later coordination with oocyte retrieval.
This data should provide reassurance to those practitioners and
laboratory directors that may have concerns regarding the use of
an offsite location for testicular extraction.
The use of spermatozoa retrieved from testes in men with
azoospermia with subsequent fertilization of oocytes via ICSI was
reported in 1994. [35] Rates of oocyte fertilization with
TESEICSI have been reported to be between 45%–82%. [25–
27,35,36] When comparing men with two common types of
obstructive azoospermia (congenital bilateral absence of the vas
deferens and prior vasectomy) the only difference was in their age
with men with a prior vasectomy as well as their female partners
being significantly older than their CBAVD counterparts. We
found no difference in pregnancy rate among these two subgroups.
In men with NOA, sperm recovery and fertilization remains
challenging, with lower recovery (60–70%) and fertilization rates
(47–55%) compared to men with obstructive azoospermia.
[8,16,37–39] In our laboratory, we documented a significantly
higher rate of fertilization among men with obstructive azoospermia compared to men with NOA. Our findings are consistent with
other experts who note lower sperm freeze-thaw rates with NOA
than other etiologies. Ultimately, for men with NOA, the preferred
method of sperm retrieval involves microdissection TESE.[22,40–
42]Intracytoplasmic sperm injection with sperm from TESE has
radically changed the options available to these men.
Another observation worthy of notice was the effect of
underlying female factor infertility on TESE/ICSI outcome
particularly as it relates to pregnancy outcome. In our experience,
men with azoospermia whose partners had diminished ovarian
reserve had fertilization rates with TESE similar to those men
whose partners had no known contributing female factor.
However, implantation rate and delivery rate were significantly
reduced in the group of patients that had contributing DOR
(Table 5). Not surprisingly, women in the DOR group were older
than those females with no known contributing female factor.
These findings reinforce the challenges in achieving pregnancy in
women with DOR, and although the fertilization rates may be
similar, pregnancy rates remain poor with concomitant sever male
factor. p.
Studies have indicated no difference in pregnancy rates in
oocytes fertilized with fresh TESE sperm versus frozen-thawed
TESE sperm. [13,16,43–47] Advantages of the latter method
include 1) presence of reliable sperm at the time of oocyte retrieval
and 2) avoiding repeat biopsy which may threaten testicular
function in men with NOA. [48] Others however, suggest that the
use of fresh sperm after TESE in IVF-ICSI cycles yields better
fertilization and pregnancy rates. [49,50] In males with all
diagnoses frozen TESE sperm resulted in a better fertilization
rate compared to fresh TESE sperm. [47] Pregnancy rates were
similar between the two groups, though. In a subgroup analysis of
men with non-obstructive azoospermia, there was no difference in
pregnancy rate between the use of fresh and frozen-thawed TESE
sperm [32].
The use of intracytoplasmic sperm injection and the evolution of
testicular extraction of sperm have provided an opportunity for
men to have their own biological child. Previously, these men had
no options. TESE-ICSI has been a part of modern day infertility

Discussion
Previous reports on sperm recovery rates from either the
epididymis or testes have ranged from 45 to 73%. [16,21–27] In
men with NOA, the success rates have been significantly lower,
from 25–50% [21,22,28], but are improved when increasing the
sample area [29–31]. Our experience using fresh and frozen
TESE sperm in ICSI cycles was consistent with prior reports in
regard to sperm recovery and fertilization outcomes. [12,13,32]
Unlike previous studies that focused on fresh versus frozen TESE
sperm in obstructive azoospermia, in this report we included all
male factor diagnoses, including non-obstructive azoospermia.
Ambulatory surgery centers have become much more common
in the United States due to advances in surgical procedures and
anesthesia. [33] In 2006, there were 4,700 ASCs in the United
PLOS ONE | www.plosone.org
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practice for 15 years and cryopreservation techniques have
provided reliable coordination with oocyte retrieval. Despite the
advances, azoospermia remains a challenging component of male
factor infertility.
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